Gadget News Software Technology

Ablation Equipments Market Report- Trends, opportunities and forecast in this composites market to 2026

ReportsnReports added a new report on The Ablation Equipments Market report that delivers the clean elaborated structure of the Report comprising each and every business-related information of the market at a global level. The in-depth study on the current state which focuses on the major drivers and restraints for the key players. Ablation Equipments Market Industry research report provides granular analysis of the market share, segmentation, revenue forecasts, geographic regions of the market and analytical tools such as SWOT analysis to generate a whole set of trade based studies regarding the Ablation Equipments Market .

Get FREE PDF Sample of the report @  https://www.reportsnreports.com/contacts/requestsample.aspx?name=1264160

Ablation Equipments Market Top Companies and Product Overview 
AngioDynamics Inc Company Overview
CPSI Biotech Company Overview
Creo Medical Ltd. Company Overview
Harmonic Medical Inc Company Overview
HistoSonics Inc Company Overview
Hospital for Special Surgery Company Overview

and more…

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ablation Equipments pipeline products.

Scope of this Report-
– Extensive coverage of the Ablation Equipments under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Ablation Equipments and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy this Report-
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Ablation Equipments under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=1264160

Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Ablation Equipments Overview 8
3 Products under Development 9
3.1 Ablation Equipments – Pipeline Products by Stage of Development 9
3.2 Ablation Equipments – Pipeline Products by Territory 10
3.3 Ablation Equipments – Pipeline Products by Regulatory Path 11
3.4 Ablation Equipments – Pipeline Products by Estimated Approval Date 12
3.5 Ablation Equipments – Ongoing Clinical Trials 13
4 Ablation Equipments – Pipeline Products under Development by Companies 14
4.1 Ablation Equipments Companies – Pipeline Products by Stage of Development 14
4.2 Ablation Equipments – Pipeline Products by Stage of Development 15
5 Ablation Equipments Companies and Product Overview 16
5.1 AngioDynamics Inc Company Overview 16
5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 CPSI Biotech Company Overview 28
5.2.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Creo Medical Ltd. Company Overview 30
5.3.1 Creo Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Harmonic Medical Inc Company Overview 32
5.4.1 Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.5 HistoSonics Inc Company Overview 35
5.5.1 HistoSonics Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 Hospital for Special Surgery Company Overview 38
5.6.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 38
5.7 Imricor Medical Systems Inc Company Overview 39
5.7.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.8 Innoblative Designs, Inc. Company Overview 42
5.8.1 Innoblative Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 Integra LifeSciences Holdings Corp Company Overview 43
5.9.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Intratherm, Llc Company Overview 44
5.10.1 Intratherm, Llc Pipeline Products & Ongoing Clinical Trials Overview 44
5.11 Medtronic plc Company Overview 45
5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 45
5.12 Memorial Sloan Kettering Cancer Center Company Overview 47
5.12.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 47
5.13 Mirabilis Medical Inc Company Overview 48
5.13.1 Mirabilis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.14 Prosurg Inc Company Overview 51
5.14.1 Prosurg Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.15 Pulse Biosciences, Inc. Company Overview 52
5.15.1 Pulse Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.16 Southern Illinois University Carbondale Company Overview 57
5.16.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 57
5.17 Thermedical Inc Company Overview 58
5.17.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 58
5.18 TransEnterix, Inc. Company Overview 59
5.18.1 TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.19 University of California San Francisco Company Overview 60
5.19.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 60
5.20 University of Texas at Austin Company Overview 61
5.20.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 61
5.21 University of Wisconsin-Stout Company Overview 62
5.21.1 University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 62
6 Ablation Equipments- Recent Developments 63
6.1 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors 63
6.2 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 63
6.3 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 66
6.4 Nov 07, 2017: Misonix Reports First Quarter Fiscal Year 2018 Financial Results 67
6.5 Nov 06, 2017: Ethicon Celebrates 130 Years of Transforming Surgery to Advance Patient Outcomes 68
6.6 Nov 03, 2017: Smith & Nephew Third Quarter 2017 Trading Report 68
6.7 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 69
6.8 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 70
6.9 Oct 26, 2017: Stryker reports third quarter 2017 results 70
6.10 Oct 26, 2017: Integra LifeSciences Reports Third Quarter 2017 Financial Results 72
6.11 Oct 25, 2017: Baylis Medical’s Kris Shah appointed to AdvaMed Accel Board of Directors 73
6.12 Oct 19, 2017: CLS signs supplier agreement with University of Texas Medical Branch and receives the first order 73
6.13 Oct 18, 2017: Relievant Medsystems Names Ray M. Baker, M.D. as Chief Medical Officer 74
6.14 Oct 09, 2017: Smith & Nephew: Notice of Chief Executive Officer’s intention to retire by end of 2018 74
6.15 Oct 09, 2017: Notice of Chief Executive Officer’s intention to retire by end of 2018 75
6.16 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 75
6.17 Oct 02, 2017: Smith & Nephew Announces Directorate Change 77
6.18 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 77
6.19 Sep 26, 2017: Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Anasco, Puerto Rico 78
6.20 Sep 20, 2017: SonaCare Medical Reports that CMS Announces Increase to ASC Payment for HIFU Prostate Ablation 78
6.21 Sep 19, 2017: Relievant Medsystems Names Kevin Hykes Chief Executive Officer 79
6.22 Sep 19, 2017: HistoSonics Expands Leadership Team As It Accelerates Growth 79
6.23 Sep 18, 2017: Smith & Nephew Announces Change in Board of Directors 81
6.24 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director 81
6.25 Sep 11, 2017: Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTx System 81
6.26 Aug 23, 2017: Misonix Appoints Joseph Dwyer as Chief Financial Officer 82
6.27 Aug 23, 2017: Baylis Medical strengthens global expansion plans with senior hire 82
6.28 Aug 22, 2017: Misonix Reports Fiscal Year 2017 Financial Results 83
6.29 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 84
6.30 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 87
6.31 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 87
6.32 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 87
6.33 Jul 27, 2017: Stryker reports second quarter 2017 results 91
6.34 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results 92
6.35 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 92
6.36 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 94
6.37 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 96
6.38 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 96
6.39 Jun 29, 2017: FDA Confirms 510(K) Submission Pathway For Creo’s Flexible Ablation System 97
6.40 Jun 19, 2017: CSA Medical Appoints Jean Bjerke, Vice President of Marketing 97
6.41 Jun 07, 2017: AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System 98
6.42 Jun 07, 2017: HistoSonics Announces Addition to Management Team 98
6.43 Jun 06, 2017: Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions 99
6.44 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 99
6.45 May 17, 2017: Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million 102
6.46 May 12, 2017: Smith & Nephew opens state-of-the-art Research & Development Centre 104
6.47 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures 104
6.48 May 05, 2017: Smith & Nephew 2017 First Quarter Trading Report 105
6.49 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results 107
6.50 May 04, 2017: Olympus Extends Portfolio of EndoTherapy Solutions at DDW 108
6.51 May 02, 2017: Misonix Reports Third Quarter Fiscal Year 2017 Financial Results 109
6.52 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 109
6.53 Apr 25, 2017: Stryker reports first quarter 2017 results 111
6.54 Apr 20, 2017: Key Appointment to Board of Directors at Cianna Medical 112
6.55 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 113
6.56 Mar 23, 2017: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment 114
6.57 Mar 23, 2017: Mirabilis receives FDA approval for US clinical study 115
6.58 Mar 14, 2017: Pulse Biosciences Submits 510(k) Application to FDA for PulseTx System 115
6.59 Mar 14, 2017: AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System 115
6.60 Mar 13, 2017: Misonix Announces Second Quarters of Fiscal 2017 116
6.61 Mar 13, 2017: HistoSonics Appoints Mike Blue as CEO and Board Member 117
6.62 Mar 13, 2017: Misonix Files Forms 10-Q for First and Second Quarters of Fiscal 2017 117
6.63 Mar 06, 2017: AtriCure Announces hiring of Senior Vice President of Clinical, Regulatory, and Scientific Affairs 119
6.64 Mar 06, 2017: TransEnterix Reports Operating Results for the Fourth Quarter and Full Year 2016 119
6.65 Feb 28, 2017: AtriCure Reports Fourth Quarter and Full Year 2016 Financial Results 120
6.66 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 121
6.67 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 123
6.68 Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million 126
6.69 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 127
6.70 Feb 09, 2017: Smith & Nephew: Directorate Change 132
6.71 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 132
6.72 Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer 133
6.73 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 134
6.74 Jan 17, 2017: Aurora Cancer Care is first in Wisconsin to perform new Nanoknife therapy technique to treat pancreatic and liver cancers 135
6.75 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 136
6.76 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 136
6.77 Jan 09, 2017: AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2016 138
6.78 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 139
6.79 Dec 19, 2016: Stavros G. Vizirgianakis Appointed President and CEO of Misonix 140
7 Appendix 142
7.1 Methodology 142

amd more